ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
230.83
+0.18 (0.08%)
Aug 20, 2026, 11:21 AM EDT - Market open
ResMed Employees
ResMed had 11,370 employees as of June 30, 2026. The number of employees increased by 770 or 7.26% compared to the previous year.
Employees
11,370
Change (1Y)
770
Growth (1Y)
7.26%
Revenue / Employee
$497,225
Profits / Employee
$133,975
Market Cap
33.30B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 11,370 | 770 | 7.26% |
| Jun 30, 2025 | 10,600 | 620 | 6.21% |
| Jun 30, 2024 | 9,980 | -160 | -1.58% |
| Jun 30, 2023 | 10,140 | 1,980 | 24.26% |
| Jun 30, 2022 | 8,160 | 190 | 2.38% |
| Jun 30, 2021 | 7,970 | 200 | 2.57% |
| Jun 30, 2020 | 7,770 | 530 | 7.32% |
| Jun 30, 2019 | 7,240 | 1,300 | 21.89% |
| Jun 30, 2018 | 5,940 | -140 | -2.30% |
| Jun 30, 2017 | 6,080 | 830 | 15.81% |
| Jun 30, 2016 | 5,250 | 910 | 20.97% |
| Jun 30, 2015 | 4,340 | 240 | 5.85% |
| Jun 30, 2014 | 4,100 | 200 | 5.13% |
| Jun 30, 2013 | 3,900 | 200 | 5.41% |
| Jun 30, 2012 | 3,700 | 250 | 7.25% |
| Jun 30, 2011 | 3,450 | 250 | 7.81% |
| Jun 30, 2010 | 3,200 | 300 | 10.34% |
| Jun 30, 2009 | 2,900 | 200 | 7.41% |
| Jun 30, 2008 | 2,700 | 0 | - |
| Jun 30, 2007 | 2,700 | 200 | 8.00% |
| Jun 30, 2006 | 2,500 | 573 | 29.74% |
| Jun 30, 2005 | 1,927 | 407 | 26.78% |
| Jun 30, 2004 | 1,520 | 56 | 3.83% |
| Jun 30, 2003 | 1,464 | 214 | 17.12% |
| Jun 30, 2002 | 1,250 | 297 | 31.16% |
| Jun 30, 2001 | 953 | 348 | 57.52% |
| Jun 30, 2000 | 605 | 104 | 20.76% |
| Jun 30, 1999 | 501 | 111 | 28.46% |
| Jun 30, 1998 | 390 | 106 | 37.32% |
| Jun 30, 1997 | 284 | 55 | 24.02% |
| Jun 30, 1996 | 229 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Becton, Dickinson and Company | 72,000 |
| Medline | 45,000 |
| Baxter International | 37,500 |
| Alcon | 25,942 |
| Solventum | 20,584 |
| Align Technology | 20,290 |
| The Cooper Companies | 15,000 |
| AptarGroup | 14,000 |
RMD News
- 1 day ago - ResMed initiated with a Neutral at Rothschild & Co Redburn - TheFly
- 1 day ago - ResMed management to meet with KeyBanc - TheFly
- 2 days ago - Resmed Announces Appointment of Carol Burt as Lead Director and Planned Retirement of Director Ron Taylor - GlobeNewsWire
- 12 days ago - ResMed shares tumble as weak 2027 sales forecast eclipses quarterly profit beat - Reuters
- 13 days ago - ResMed price target raised to $244 from $234 at RBC Capital - TheFly
- 13 days ago - ResMed price target lowered to $213 from $217 at Baird - TheFly
- 13 days ago - ResMed price target lowered to $215 from $225 at Wells Fargo - TheFly
- 13 days ago - ResMed price target lowered to $255 from $260 at KeyBanc - TheFly